NUVB Company Profile and Key Details
Nuvation Bio Inc.
NUVB Stock Price Chart
Stock Price Today
Nuvation Bio Inc. (NUVB) stock surged +2.71%, trading at $2.65 on NYSE, up from the previous close of $2.58. The stock opened at $2.57, fluctuating between $2.55 and $2.73 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an adenosine receptor inhibitor; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as PARP inhibitor to address ER+ breast and ovarian cancer. The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York.
Company Information
| Employees | 203 |
| Beta | 1.36 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Nuvation Bio Inc. (NYSE: NUVB) stock price is $2.65 in the last trading session. During the trading session, NUVB stock reached the peak price of $2.73 while $2.55 was the lowest point it dropped to. The percentage change in NUVB stock occurred in the recent session was 2.71% while the dollar amount for the price change in NUVB stock was $0.07.
The NYSE listed NUVB is part of Biotechnology industry that operates in the broader Healthcare sector. Nuvation Bio Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Gary Hattersley Ph.D.
Chief Scientific Officer
Dr. David C. Hanley Ph.D.
Chief Technical Operations Officer
Dr. David Liu M.D., Ph.D.
Chief Medical Officer
Ms. Jennifer A. Fox
Chief Financial Officer & Sec.
Ms. Stacy Markel
Chief People Officer
Dr. David T. Hung M.D.
Founder, Pres, Chief Executive Officer & Director
Ms. Kerry A. Wentworth
Chief Regulatory Officer
NUVB's closing price is 74.34% higher than its 52-week low of $1.52 where as its distance from 52-week high of $4.16 is -36.3%.
Number of NUVB employees currently stands at 203.
Official Website of NUVB is: https://www.nuvationbio.com
NUVB could be contacted at phone 332 208 6102 and can also be accessed through its website. NUVB operates from 1500 Broadway, New York, NY 10036, United States.
NUVB stock volume for the day was 2.15M shares. The average number of NUVB shares traded daily for last 3 months was 2.49M.
The market value of NUVB currently stands at $891.90M with its latest stock price at $2.65 and 336.57M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com